AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,808,441 | +8.3% | 273,002 | 0.0% | 0.31% | +13.7% |
| Q2 2023 | $12,746,463 | +12.7% | 273,002 | -7.6% | 0.27% | +35.5% |
| Q1 2023 | $11,305,907 | -34.6% | 295,502 | -6.3% | 0.20% | -45.2% |
| Q4 2022 | $17,289,510 | -25.3% | 315,502 | -53.6% | 0.36% | -40.1% |
| Q3 2022 | $23,154,000 | +80.3% | 680,000 | -50.0% | 0.61% | +121.5% |
| Q2 2022 | $12,843,000 | -33.4% | 1,359,052 | -0.0% | 0.28% | -31.8% |
| Q1 2022 | $19,286,000 | -32.9% | 1,359,152 | 0.0% | 0.40% | -9.2% |
| Q4 2021 | $28,746,000 | -16.5% | 1,359,152 | -11.8% | 0.44% | -1.3% |
| Q3 2021 | $34,429,000 | -16.2% | 1,540,465 | -7.0% | 0.45% | +6.4% |
| Q2 2021 | $41,102,000 | -14.5% | 1,656,673 | 0.0% | 0.42% | -10.9% |
| Q1 2021 | $48,060,000 | +12.4% | 1,656,673 | 0.0% | 0.48% | +39.7% |
| Q4 2020 | $42,742,000 | -16.2% | 1,656,673 | 0.0% | 0.34% | -11.9% |
| Q3 2020 | $51,009,000 | +93.7% | 1,656,673 | +56.8% | 0.39% | +60.2% |
| Q2 2020 | $26,332,000 | +39.4% | 1,056,673 | +18.6% | 0.24% | -5.5% |
| Q1 2020 | $18,893,000 | -4.5% | 891,201 | 0.0% | 0.26% | +3.7% |
| Q4 2019 | $19,780,000 | +16.0% | 891,201 | +18.9% | 0.25% | +5.1% |
| Q3 2019 | $17,049,000 | +109.5% | 749,424 | +76.3% | 0.23% | +28.6% |
| Q2 2019 | $8,139,000 | – | 425,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |